**Core Concept**
Proliferation-independent agents are a class of drugs that exert their effects by mechanisms that do not directly interfere with cell division or DNA replication. These agents can target various cellular processes such as angiogenesis, apoptosis, or cell signaling pathways.

**Why the Correct Answer is Right**
Proliferation-independent agents can induce cell death or inhibit cellular functions by targeting specific molecular pathways. For example, angiogenesis inhibitors like bevacizumab target vascular endothelial growth factor (VEGF) to prevent tumor blood vessel formation. Apoptosis-inducing agents like bortezomib work by inhibiting the proteasome, leading to the accumulation of defective proteins and ultimately triggering programmed cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a proliferation-independent agent.
**Option B:** This option is incorrect because it is a type of chemotherapeutic agent that directly interferes with DNA replication, making it a proliferation-dependent agent.
**Option C:** This option is incorrect because it is a type of targeted therapy that directly interferes with cell signaling pathways, making it a proliferation-dependent agent.

**Clinical Pearl / High-Yield Fact**
Proliferation-independent agents can be effective in treating cancers that are resistant to traditional chemotherapy or have limited response to targeted therapies.

**Correct Answer: B. A type of chemotherapeutic agent that directly interferes with DNA replication, making it a proliferation-dependent agent.**